Adial Pharmaceuticals Enters Into Option Agreement for Sale of Purnovate Assets to Adenomed 
Adial Pharmaceuticals Enters Into Option Agreement for Sale of Purnovate Assets to Adenomed
Adial to focus on late-stage clinical development for AD04 for alcohol use disorder; potential sale of Purnovate to new company...
Lisata Therapeutics Announces Participation in Upcoming Conferences in February
BASKING RIDGE, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
Pardes Biosciences to Present at SVB Securities Global Biopharma Conference
CARLSBAD, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as...
Teladoc Health to Announce Fourth Quarter 2022 Financial Results
PURCHASE, NY, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care,...
H1 is Named to the New York Digital Health 100 For Second Straight Year
Exclusive list recognizes most exciting and innovative health startups in the New York regionNEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE)...
ResolutionRx Ltd, a wholly owned subsidiary of RespireRx Pharmaceuticals Inc. Enters into LOI and Term Sheet with Radium Capital for the financing of anticipated Research and Development Credits
Glen Rock, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a...
Novo Nordisk files annual report with the SEC
Bagsværd, Denmark, 1 February 2023 – Novo Nordisk A/S has filed its Annual Report 2022 on Form 20-F for the...
OrthoPediatrics Corp. Publishes Environmental, Social, and Governance (“ESG”) Summary Report
WARSAW, Ind., Feb. 01, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively...
Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline Evaluation
FDA Agrees to Extended Milestones for Long-Term Twirla® Safety Study New Publication Supports Eventual Pursuit of AG200-15 Extended Regimen Development...
Cue Biopharma to Present at Two February 2023 Scientific Conferences
BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of...
Recludix Pharma to Present at the Guggenheim Healthcare Talks Oncology Conference
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging...
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science...
Bolt Biotherapeutics to Present at February Investor Conferences
REDWOOD CITY, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immuno-oncology...
United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement
Mesquite, NV, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the...
HOOPP adds Ottawa-based homecare organization Carefor, expanding access to retirement security for healthcare workers
TORONTO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) was pleased to begin the new...
NeuroSigma Announces Strategic Digital Marketing Partnership with Data360
LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS)...
UTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance
SALT LAKE CITY, UT, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. (Nasdaq: UTMD) finished...
Israeli Biotech Clearmind Medicine Announces Positive Pre-Clinical Results Treating Major Depression With a Novel Ketamine-Based Compound
Tel Aviv, Israel / Vancouver, Canada, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE:...
Healix International opens Vancouver office in response to growing demand for crisis and security risk management services
The new office and growing team will enhance operational capability in the Americas in response to an increasing demand for...
SomaLogic announces Certified Site expansion through world-class multiomics initiative with Group 42 Healthcare
BOULDER, Colo., Jan. 31, 2023 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced the...